THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 101 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,052 | -71.6% | 20,400 | -65.9% | 0.00% | -100.0% |
| Q2 2023 | $619,054 | +96.5% | 59,812 | +299.0% | 0.00% | -50.0% |
| Q2 2020 | $315,000 | +71.2% | 14,990 | +83.7% | 0.00% | +100.0% |
| Q1 2019 | $184,000 | +76.9% | 8,160 | +100.0% | 0.00% | 0.0% |
| Q4 2018 | $104,000 | -99.2% | 4,080 | -99.0% | 0.00% | -98.8% |
| Q4 2016 | $13,035,000 | +355.0% | 408,880 | +417.1% | 0.09% | +330.0% |
| Q3 2016 | $2,865,000 | +432.5% | 79,068 | +233.5% | 0.02% | +300.0% |
| Q2 2016 | $538,000 | – | 23,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |